Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Yuntianhua Group is a prominent Chinese state-owned conglomerate and a global leader in the phosphate chemical industry. While its core operations focus on mining, fertilizers, and modern agriculture, the group holds a strategic position in the healthcare sector through its significant investment in Yunnan Baiyao Group, one of China's most recognized pharmaceutical companies. Yuntianhua's portfolio includes the production of fine chemicals and feed-grade additives that serve the food and life science industries. Headquartered in Kunming, the company operates a vast manufacturing network and is a key driver of industrial development in Southwest China. Its primary listed subsidiary, Yunnan Yuntianhua Co., Ltd., is a major player on the Shanghai Stock Exchange.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yuntianhua.